MRS4596, a potent and selective antagonist of the P2X4 receptor, exhibits an IC50 of 1.38 µM for the human P2X4 receptor. This compound demonstrates both neuroprotective and neuro-rehabilitative effects in ischemic stroke models, making it valuable for research purposes in the context of ischemic stroke.
Molekulargewicht:
439.42
Formel:
C21H14N5NaO3S
Target-Kategorie:
P2X Receptor|||Others
T73452
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
